Skip to main content

Table 2 Pathogen Distribution in Patients with HCAP and CAPa

From: Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital

Microbes

HCAP (n= 231)

CAP (n= 296)

P-value

Pathogen identified

79 (34.2)

83 (29.1)

0.206

Gram-positive pathogens

34 (14.7)

54 (18.2)

0.282

   MRSA

9 (3.9)

6 (2.0)

 

   MSSA

4 (1.7)

9 (3.0)

 

   Streptococcus pneumoniae

11 (4.8)

33 (11.1)

 

   Streptococcus other

4 (1.7)

3 (1.0)

 

   Enterococcus species

0 (0)

1 (0.3)

 

   Others b

6 (2.6)

3 (1.0)

 

Gram-negative pathogens

46 (19.9)

28 (9.5)

0.001

   Pseudomonas aeruginosa

10 (4.3)

5 (1.7)

 

   Escherichia coli

1 (0.4)

0 (0)

 

   Haemophilus influenzae

2 (0.9)

3 (1.0)

 

   Klebsiella pneumoniae

23 (10.0)

13 (4.4)

 

ESBL producing c

9/23 (39.1)

3/13 (23.1)

 

   Enterobacter species

4 (1.7)

1 (0.3)

 

   Acinetobacter baumannii

1 (0.4)

0 (0)

 

   Stenotrophomonas maltophilia

1 (0.4)

1 (0.3)

 

   Others d

4 (1.7)

5 (1.7)

 

Anaerobes e

1 (0.4)

0 (0)

 

Atypical pathogens f

0 (0)

3 (1.0)

 

Fungal pathogensg

1 (0.4)

1 (0.3)

 

PDR pathogens

29 (12.6)

14 (4.7)

0.001

  1. a Data are presented as numbers (percentages) unless otherwise indicated.
  2. b Coagulase-negative Staphylococci species
  3. c Number of patients/total number of patients in whom Klebsiella pneumonia was identified (percentages)
  4. d Moraxella catarrhalis (1 in HCAP and 3 in CAP), Serratia marcescens (2 in HCAP and 2 in CAP), Citrobacter freundii (1 in HCAP)
  5. e Bacteroides fragilis
  6. f Mycoplasma pneumonia (3 in CAP)
  7. g Aspergillus species
  8. HCAP healthcare-associated pneumonia
  9. CAP community-acquired pneumonia
  10. MRSA methicillin-resistant Staphylococcus aureus
  11. MSSA methicillin-sensitive Staphylococcus aureus
  12. ESBL extended-spectrum β-lactamase
  13. PDR potentially drug-resistant